Drug Topics July 2020

July 27, 2020

“I just hope that pharmacists’ judgment can soon be a contributing factor in pharmacotherapy decisions made by PBMs and insurance companies.”

July 24, 2020

An inside look at the process from prescription to dispensing.

July 22, 2020

On May 8, 2020, the FDA granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company).

July 21, 2020

Prepare to counsel patients on microbiome-related products.

July 20, 2020

Preparation taking place in some pharmacies, but clarification is still needed.

July 17, 2020

Once largely stigmatized, illicit substances are breaking into the field of pain management.

July 16, 2020

Despite some anticipated hesitancy, demand for the novel coronavirus vaccine will be significant when it becomes available.

July 15, 2020

“Pharmacists should ensure that patients have a written asthma action plan.”

July 14, 2020

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

June 19, 2020

In response to the study, the NYC Department of Health is pursuing large-scale implementation of this approach, targeting diabetes hot spots across the city through public health messaging, mailed print materials, and Care Calls.

June 18, 2020

“We know that if we don’t address these potential difficulties before they occur, the burden to families can be devastating and the health care costs are tremendous.”

May 26, 2020

In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.